Related references
Note: Only part of the references are listed.Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease
Afzal Misrani et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Efficacy of delta(9) -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice
Prakash Nidadavolu et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
The Essential Medicinal Chemistry of Cannabidiol (CBD)
Kathryn M. Nelson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Acute Cannabinoids Produce Robust Anxiety-Like and Locomotor Effects in Mice, but Long-Term Consequences Are Age- and Sex-Dependent
Chelsea R. Kasten et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2019)
The neuropathological diagnosis of Alzheimer's disease
Michael A. DeTure et al.
MOLECULAR NEURODEGENERATION (2019)
Amyloid-beta and tau complexity - towards improved biomarkers and targeted therapies
Juan Carlos Polanco et al.
NATURE REVIEWS NEUROLOGY (2018)
The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms
Inhae Kang et al.
FEBS LETTERS (2018)
Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol
Yosef Sarne et al.
NEUROBIOLOGY OF AGING (2018)
MFF-dependent mitochondrial fission regulates presynaptic release and axon branching by limiting axonal mitochondria size
Tommy L. Lewis et al.
NATURE COMMUNICATIONS (2018)
A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice
Andras Bilkei-Gorzo et al.
NATURE MEDICINE (2017)
Comparison of Adult Hippocampal Neurogenesis and Susceptibility to Treadmill Exercise in Nine Mouse Strains
Jong Whi Kim et al.
NEURAL PLASTICITY (2017)
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
Georgia Watt et al.
FRONTIERS IN PHARMACOLOGY (2017)
In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains
Ambika Krishnankutty et al.
SCIENTIFIC REPORTS (2017)
Searching for cognitive enhancement in the Morris water maze: better and worse performance in D-amino acid oxidase knockout (Dao-/-) mice
David Pritchett et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Lithium Promotes Longevity through GSK3/NRF2-Dependent Hormesis
Jorge Ivan Castillo-Quan et al.
CELL REPORTS (2016)
D-amino acid oxidase knockout (Dao-/-) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption
David Pritchett et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2015)
Tetrahydrocannabinol Induces Brain Mitochondrial Respiratory Chain Dysfunction and Increases Oxidative Stress: A Potential Mechanism Involved in Cannabis-Related Stroke
Valerie Wolff et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-beta Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
Stina Tucker et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Cannabinoid Effects on beta Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro
Emelie Janefjord et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2014)
Assessing Spatial Learning and Memory in Rodents
Charles V. Vorhees et al.
ILAR JOURNAL (2014)
The Potential Therapeutic Effects of THC on Alzheimer's Disease
Chuanhai Cao et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice
David Cheng et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement
Caterina Scuderi et al.
PHYTOTHERAPY RESEARCH (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
Optimized Protocol for Amyloid-β Extraction from the Brain
Maria Izco et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy
Maria J. Casarejos et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
mtDNA makes a U-turn for the mitochondrial nucleoid
Christian Kukat et al.
TRENDS IN CELL BIOLOGY (2013)
Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro
Benjamin S. Harvey et al.
NEUROTOXICOLOGY (2012)
Synapses and Dendritic Spines as Pathogenic Targets in Alzheimer's Disease
Wendou Yu et al.
NEURAL PLASTICITY (2012)
An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions
Rebecca D. Crean et al.
JOURNAL OF ADDICTION MEDICINE (2011)
Amyloid-beta Toxicity and Tau Hyperphosphorylation are Linked Via RCAN1 in Alzheimer's Disease
Ana Lloret et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
Ana Maria Martin-Moreno et al.
MOLECULAR PHARMACOLOGY (2011)
Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease
Lars M. Ittner et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Cannabidiol Reduces Ab- Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
Giuseppe Esposito et al.
PLOS ONE (2011)
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
Michael Ewers et al.
TRENDS IN NEUROSCIENCES (2011)
Dementia Incidence Continues to Increase with Age in the Oldest Old The 90+Study
Maria M. Corrada et al.
ANNALS OF NEUROLOGY (2010)
The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease
Felix Hernandez et al.
FEBS LETTERS (2008)
Glycogen synthase kinase-3β, or a link between amyloid and tau pathology?
D. Muyllaert et al.
GENES BRAIN AND BEHAVIOR (2008)
Amyloid-β binds to the extracellular cysteine-rich domain of frizzled and inhibits wnt/β-catenin signaling
Margaret H. Magdesian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
G. Esposito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Altered plasma cytokine levels in Alzheimer's disease: Correlation with the disease progression
M. Motta et al.
IMMUNOLOGY LETTERS (2007)
Detecting amyloid-β aggregation with fiber-based fluorescence correlation spectroscopy
Kanchan Garai et al.
BIOPHYSICAL JOURNAL (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
GSK-3 beta regulation in skeletal muscles by adrenaline and insulin: Evidence that PKA and PKB regulate different pools of GSK-3
Jorgen Jensen et al.
CELLULAR SIGNALLING (2007)
A chaperone-dependent GSK3β transitional intermediate mediates activation-loop autophosphorylation
Pamela A. Lochhead et al.
MOLECULAR CELL (2006)
Associative and motor learning in 12-month-old transgenic APP+PS1 mice
Michael Ewers et al.
NEUROBIOLOGY OF AGING (2006)
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement
Giuseppe Esposito et al.
NEUROSCIENCE LETTERS (2006)
The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells
G Esposito et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice
Jennifer Alamed et al.
NATURE PROTOCOLS (2006)
The relationship of CSF and plasma cytokine levels to cerebral white matter injury in the premature newborn
VJ Ellison et al.
PEDIATRIC RESEARCH (2005)
Amyloid β peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology
J Attems et al.
ACTA NEUROPATHOLOGICA (2004)
Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis
M Tachikawa et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Male mice exhibit better spatial working and reference memory than females in a water-escape radial arm maze task
JE Gresack et al.
BRAIN RESEARCH (2003)
Behavioral assessment of Alzheimer's transgenic mice following long-term Aβ vaccination:: Task specificity and correlations between Aβ deposition and spatial memory
GW Arendash et al.
DNA AND CELL BIOLOGY (2001)
Pharmacology and effects of cannabis: a brief review
CH Ashton
BRITISH JOURNAL OF PSYCHIATRY (2001)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Share Paper
